Zhejiang Raygene Pharmaceuticals Co., Ltd
3 clinical trials · Sponsor
◉ Watch Zhejiang Raygene Pharmaceuticals Co., Ltd
| Record | Firm | Date |
|---|---|---|
| A Phase II/III Trial Comparing Transarterial Tirapazamine Embolization (TATE) With cTACE for Intermediate-stage Liver Cancer. (NCT06844357) | Zhejiang Raygene Pharmaceuticals Co., Ltd | 2025-03-27 |
| TATE and KN046 in MCRC (NCT06834399) | Zhejiang Raygene Pharmaceuticals Co., Ltd | 2023-04-27 |
| Evaluate the Effect of Tirazamine on Primary Liver Cancer. (NCT06848556) | Zhejiang Raygene Pharmaceuticals Co., Ltd | 2021-05-14 |
Track Zhejiang Raygene Pharmaceuticals Co., Ltd automatically
Every clearance here is in the API, with alerts when new ones post.